{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:17Z","timestamp":1787032817427,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110369","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:09:23Z","timestamp":1780787363000},"source":"Crossref","is-referenced-by-count":1,"title":["Drug-Induced Pemphigus Vulgaris Following Ceftriaxone Use"],"prefix":"10.7759","author":[{"given":"Alpha","family":"Amadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholette","family":"Murray-Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Gayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perkins","family":"Mukunyadzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Mark P","family":"Pabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches","volume":"54","author":"Pollmann R","year":"2018","unstructured":"Pollmann R, Schmidt T, Eming R, Hertl M. Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches. Clin Rev Allergy Immunol. 2018, 54:1-25. 10.1007\/s12016-017-8662-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107299","article-title":"Drug-induced pemphigus: a systematic review of 170 patients","volume":"92","author":"Ghaedi F","year":"2021","unstructured":"Ghaedi F, Etesami I, Aryanian Z, et al.. Drug-induced pemphigus: a systematic review of 170 patients. Int Immunopharmacol. 2021, 92:107299. 10.1016\/j.intimp.2020.107299","journal-title":"Int Immunopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt E","year":"2019","unstructured":"Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019, 394:882-94. 10.1016\/S0140-6736(19)31778-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1508129","article-title":"A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic","volume":"15","author":"Baroukhian J","year":"2024","unstructured":"Baroukhian J, Seiffert-Sinha K, Sinha AA. A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic. Front Immunol. 2024, 15:1508129. 10.3389\/fimmu.2024.1508129","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1326359","article-title":"Pemphigus: trigger and predisposing factors","volume":"10","author":"Moro F","year":"2023","unstructured":"Moro F, Sinagra JL, Salemme A, et al.. Pemphigus: trigger and predisposing factors. Front Med (Lausanne). 2023, 10:1326359. 10.3389\/fmed.2023.1326359","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000113944","article-title":"Pemphigus vulgaris after coxsackievirus infection and cephalosporin treatment: a paraviral eruption?","volume":"216","author":"Ruocco E","year":"2008","unstructured":"Ruocco E, Lo Schiavo A, Baroni A, Sangiuliano S, Puca RV, Brunetti G, Ruocco V. Pemphigus vulgaris after coxsackievirus infection and cephalosporin treatment: a paraviral eruption?. Dermatology. 2008, 216:317-9. 10.1159\/000113944","journal-title":"Dermatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy E","year":"2015","unstructured":"Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis. J Allergy Clin Immunol. 2015, 135:745-52.e5. 10.1016\/j.jaci.2014.07.062","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","article-title":"Drug Induced Pemphigus","author":"Pile HD","year":"2023","unstructured":"Pile HD, Yarrarapu SNS, Crane JS. Drug Induced Pemphigus. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref9","unstructured":"U.S. Food and Drug Administration. Ceftriaxone sodium [drug label]. (2015). Accessed. April 10, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/050585s067lbl.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.20521","article-title":"Progress and challenges in bacterial meningitis: a review","volume":"328","author":"Hasbun R","year":"2022","unstructured":"Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA. 2022, 328:2147-54. 10.1001\/jama.2022.20521","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.2340\/00015555724849","article-title":"Drug-triggered pemphigus in a predisposed woman","volume":"72","author":"Ruocco V","year":"1992","unstructured":"Ruocco V, Gombos F, Lombardi M. Drug-triggered pemphigus in a predisposed woman. Acta Derm Venereol. 1992, 72:48-9.","journal-title":"Acta Derm Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14333","article-title":"Oroesophageal pemphigus vulgaris secondary to lisinopril use: a new side effect","volume":"13","author":"Tariq U","year":"2021","unstructured":"Tariq U, Nasrullah A, Guha A, Mitre M. Oroesophageal pemphigus vulgaris secondary to lisinopril use: a new side effect. Cureus. 2021, 13:e14333. 10.7759\/cureus.14333","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0000000000001213","article-title":"Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions","volume":"20","author":"Pandit S","year":"2024","unstructured":"Pandit S, Soni D, Krishnamurthy B, Belhekar MN. Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions. J Patient Saf. 2024, 20:236-9. 10.1097\/PTS.0000000000001213","journal-title":"J Patient Saf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.12.002","article-title":"A dire reaction: rash after amiodarone administration","volume":"126","author":"Chen A","year":"2013","unstructured":"Chen A, Sauer W, Nguyen DT. A dire reaction: rash after amiodarone administration. Am J Med. 2013, 126:301-3. 10.1016\/j.amjmed.2012.12.002","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6928363","article-title":"Immunohistopathological findings of severe cutaneous adverse drug reactions","volume":"2017","author":"Orime M","year":"2017","unstructured":"Orime M. Immunohistopathological findings of severe cutaneous adverse drug reactions. J Immunol Res. 2017, 2017:6928363. 10.1155\/2017\/6928363","journal-title":"J Immunol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001787","article-title":"Heparin-induced bullous hemorrhagic dermatosis: a report of an exceptionally exuberant case and literature review","volume":"43","author":"Cortez de Almeida RF","year":"2021","unstructured":"Cortez de Almeida RF, Vita Campos C, Daxbacher EL, Jeunon T. Heparin-induced bullous hemorrhagic dermatosis: a report of an exceptionally exuberant case and literature review. Am J Dermatopathol. 2021, 43:497-505. 10.1097\/DAD.0000000000001787","journal-title":"Am J Dermatopathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.012","article-title":"Diagnosis and clinical features of pemphigus foliaceus","volume":"29","author":"James KA","year":"2011","unstructured":"James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011, 29:405-12, viii. 10.1016\/j.det.2011.03.012","journal-title":"Dermatol Clin"},{"key":"ref19","article-title":"Bullous Pemphigoid","author":"Baigrie D","year":"2023","unstructured":"Baigrie D, Nookala V. Bullous Pemphigoid. StatPearls Publishing, Treasure Island, FL; 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488684-drug-induced-pemphigus-vulgaris-following-ceftriaxone-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:09:25Z","timestamp":1780787365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488684-drug-induced-pemphigus-vulgaris-following-ceftriaxone-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.110369","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}